Company / Tangible Book Value per Share
RAPT Therapeutics, Inc. Tangible Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$4.66
FY2024
5-year range
$3.84 / $7.53
FY2020-FY2024
Trend
+21.5%
vs FY2023
Sector context
#99 of 207
Health Care
What the data says
At $4.66, RAPT Therapeutics, Inc.'s tangible book value per share ranks #99 of 207 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 7 years, ranging from $-156.06 in FY2018 to $16.82 in FY2019.
Based on SEC 10-K filings.
4.66 in FY2024 with a 5-year CAGR of -22.6%.
Declined from $7.53 to $4.66 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- -22.6%
- 10-Year CAGR
- -
Sector benchmark
-95.8% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 21.5% year-over-year.
- Ranks #99 out of 207 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.66 | +21.5% |
| FY2023 | $3.84 | -49.1% |
| FY2022 | $7.53 | +10.7% |
| FY2021 | $6.80 | +57.6% |
| FY2020 | $4.32 | -74.3% |
| FY2019 | $16.82 | +110.8% |
| FY2018 | -$156.06 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026